Clinical trial
The Copper Metabolism MURR1 Domain 7 (COMMD7) Gene Expression in Acute Lymphoblastic Leukemia
NCT05592470 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Copper Metabolism MURR1 Domain 7 (COMMD7) Gene Expression in Acute Lymphoblastic Leukemia
- Lead sponsor
- Assiut University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2022
- Completion date
- November 30, 2024
- Enrollment
- 102 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
all